Beijing Hotgen Biotech Co Ltd (688068) Stock Price & News

Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia

About Beijing Hotgen Biotech Co Ltd

CEO-

Employees1,04 հզր

Founded23 հնս, 2005 թ.

Headquarters-

Sector-

Websitehotgen.com.cn

All values in CNY	2025 թ. սեպ	2025 թ. դեկ	2026 թ. մրտ	2026 թ. հնս
Revenue	105,80 մլն	95,17 մլն	116,03 մլն	151,72 մլն
Cost of goods sold	49,91 մլն	40,31 մլն	55,11 մլն	36,50 մլն
Cost of revenue	49,91 մլն	40,31 մլն	55,11 մլն	36,50 մլն
Research and development expenses	19,65 մլն	94,81 մլն	49,10 մլն	46,03 մլն
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	83,78 մլն	99,31 մլն	97,60 մլն	127,34 մլն
Operating expense	98,59 մլն	204,82 մլն	143,51 մլն	186,68 մլն
Total operating expenses	148,50 մլն	245,13 մլն	198,62 մլն	223,17 մլն
Operating income	-42,70 մլն	-149,96 մլն	-82,59 մլն	-71,46 մլն
Other non operating income	-273,76 հզր	2,19 մլն	-2,39 մլն	2,09 մլն
EBT including unusual items	-20,92 մլն	-155,14 մլն	-82,67 մլն	-76,94 մլն
EBT excluding unusual items	-28,82 մլն	-122,01 մլն	-69,59 մլն	-76,99 մլն
Income tax expense	4,59 մլն	-6,98 մլն	-5,78 հզր	-796,34 հզր
Effective tax rate	-21,96%	4,50%	0,01%	1,03%
Other operating expenses	-5,37 մլն	6,99 մլն	-2,96 մլն	3,17 մլն
Net income	-24,96 մլն	-107,09 մլն	-68,06 մլն	-58,07 մլն
Net profit margin	-23,59%	-112,52%	-58,66%	-38,27%
Earnings per share	-	-	-	-
Interest and investment income	14,98 մլն	35,99 մլն	15,44 մլն	3,94 մլն
Interest expense	-289,66 հզր	-7,96 մլն	-46,88 հզր	-7,63 մլն
Net interest expenses	14,69 մլն	28,03 մլն	15,39 մլն	-3,69 մլն
Depreciation and amortization charges	-	-	-	-
EBITDA	-21,62 մլն	-129,90 մլն	-62,53 մլն	-53,46 մլն
Gain or loss from assets sale	601,43 հզր	-579,43 հզր	-	6,83 հզր

Ask anything